VAERS Explorer
Back to explore

Report #2842850

Received May 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
ND
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Pyrexia

Symptom narrative

Ongoing fevers; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Ongoing fevers). The outcome of the fever was resolved. It was unknown if the reporter considered the fever to be related to Shingrix. It was unknown if the company considered the fever to be related to Shingrix. Additional Information: GSK Receipt Date: 23-MAY-2025 The pharmacist reported that ongoing fevers in the evening for two weeks following the second dose of Shingrix. The pharmacist reported that this was from a woman in her late 50s/early 60s. The fever was only in the evenings and lasted for a few weeks before dissipating.